HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model; International Journal of Molecular Sciences; Vol. 20, iss. 10

Détails bibliographiques
Parent link:International Journal of Molecular Sciences
Vol. 20, iss. 10.— 2019.— [2399, 19 p. ]
Collectivité auteur: Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора
Autres auteurs: Sokolova E. A. Evgeniya Aleksandrovna, Shilova O. N. Olga Nikolaevna, Kiselyova D. V. Darjya Vladimirovna, Shulga A. A. Aleksey Anatolievich, Balalaeva I. V. Irina Vladimirovna, Deev S. M. Sergey Mikhaylovich
Résumé:Title screen
High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors.
Langue:anglais
Publié: 2019
Sujets:
Accès en ligne:https://doi.org/10.3390/ijms20102399
Format: Électronique Chapitre de livre
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=664213

MARC

LEADER 00000naa0a2200000 4500
001 664213
005 20260506151734.0
035 |a (RuTPU)RU\TPU\network\35397 
035 |a RU\TPU\network\35057 
090 |a 664213 
100 |a 20210331d2019 k||y0rusy50 ba 
101 0 |a eng 
135 |a drcn ---uucaa 
200 1 |a HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model  |f E. A. Sokolova, O. N. Shilova, D. V. Kiselyova [et al.] 
300 |a Title screen 
320 |a [References: 37 tit.] 
330 |a High immunogenicity and systemic toxicity are the main obstacles limiting the clinical use of the therapeutic agents based on Pseudomonas aeruginosa exotoxin A. In this work, we studied the immunogenicity, general toxicity and antitumor effect of the targeted toxin DARPin-LoPE composed of HER2-specific DARPin and a low immunogenic exotoxin A fragment lacking immunodominant human B lymphocyte epitopes. The targeted toxin has been shown to effectively inhibit the growth of HER2-positive human ovarian carcinoma xenografts, while exhibiting low non-specific toxicity and side effects, such as vascular leak syndrome and liver tissue degradation, as well as low immunogenicity, as was shown by specific antibody titer. This represents prospects for its use as an agent for targeted therapy of HER2-positive tumors. 
461 |t International Journal of Molecular Sciences 
463 |t Vol. 20, iss. 10  |v [2399, 19 p. ]  |d 2019 
610 1 |a труды учёных ТПУ 
610 1 |a электронный ресурс 
610 1 |a targeted therapy 
610 1 |a DARPin 
610 1 |a Pseudomonas exotoxin A 
610 1 |a immunogenicity 
610 1 |a ovarian carcinoma 
610 1 |a HER2 
610 1 |a far-red fluorescent protein 
610 1 |a терапия 
610 1 |a рак 
701 1 |a Sokolova  |b E. A.  |g Evgeniya Aleksandrovna 
701 1 |a Shilova  |b O. N.  |g Olga Nikolaevna 
701 1 |a Kiselyova  |b D. V.  |g Darjya Vladimirovna 
701 1 |a Shulga  |b A. A.  |c biologist  |c Researcher, Tomsk Polytechnic University, Candidate of Biological Sciences  |f 1960-  |g Aleksey Anatolievich  |3 (RuTPU)RU\TPU\pers\46796 
701 1 |a Balalaeva  |b I. V.  |g Irina Vladimirovna 
701 1 |a Deev  |b S. M.  |c biologist  |c Leading Researcher, Tomsk Polytechnic University, Doctor of Biological Sciences  |f 1951-  |g Sergey Mikhaylovich  |3 (RuTPU)RU\TPU\pers\39299  |9 20959 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Физико-технический институт  |b Лаборатория № 31 ядерного реактора  |3 (RuTPU)RU\TPU\col\20054 
801 0 |a RU  |b 63413507  |c 20210331  |g RCR 
850 |a 63413507 
856 4 |u https://doi.org/10.3390/ijms20102399 
942 |c CF